纖維蛋白膠市場規模、佔有率、成長分析（按產品類型、按技術、按應用、按最終用戶、按地區）- 產業預測，2025 年至 2032 年

2023 年全球纖維蛋白膠市場規模為 5.929 億美元，預計將從 2024 年的 6.3915 億美元成長到 2032 年的 11.656 億美元，預測期內（2025-2032 年）的複合年成長率為 7.8%。

全球纖維蛋白膠市場正經歷強勁成長，主要原因是人口老化導致外科手術增多，而老化使心血管疾病和癌症等需要外科手術治療的慢性疾病更容易發生。隨著手術變得越來越頻繁和複雜，對有效止血劑的需求也日益成長，能夠快速形成穩定血塊、減少失血並加快恢復的纖維蛋白膠尤為受到青睞。此外，生物和重組DNA技術的進步正在生產出更安全、更有效的封閉劑，延長其保存期限並降低其免疫抗原性風險，從而使得合成無病原體產品成為可能。這些創新正在改善黏附性、聚合速度和整體手術效果，從而拓展纖維蛋白膠在現代醫學中的臨床應用。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

纖維蛋白膠市場規模（依產品類型及複合年成長率） （2025-2032）

• 市場概覽
• 液體
  • 冷凍纖維蛋白膠
  • 冷凍纖維蛋白膠
• 修補
• 粉末
• 其他

纖維蛋白膠市場規模（依技術及複合年成長率） （2025-2032）

• 市場概覽
• 病毒去活化
• 自體血捐獻
• 重組生產
• 其他

纖維蛋白膠市場規模（按應用和複合年成長率） （2025-2032）

• 市場概覽
• 整形外科
• 心血管外科
• 一般外科
• 移植手術
• 其他

纖維蛋白膠市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概覽
• 醫院
• 專科診所
• 其他

纖維蛋白膠市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益同比對比（2022-2024 年）

主要企業簡介

• Baxter International（USA）
• CSL Limited（Australia）
• Vivostat A/S（Denmark）
• Grifols, SA（Spain）
• Pfizer Inc.（USA）
• Stryker Corporation（USA）
• Hemarus（Australia）
• Asahi Kasei Corporation（Japan）
• Z-Medica（USA）
• Marquee Biosurgical（USA）
• Hualan Biological Engineering（China）
• CryoLife, Inc.（USA）
• Integra LifeSciences Corporation（USA）
• Becton, Dickinson and Company（USA）
• B. Braun SE（Germany）
• Corza Medical（USA/Switzerland）
• Cohera Medical（USA）
• Advanced Medical Solutions Group plc（UK）
• Ocular Therapeutix, Inc.（USA）
• MicroVal（France）

結論和建議

Global Fibrin Sealants Market size was valued at USD 592.9 million in 2023 and is poised to grow from USD 639.15 million in 2024 to USD 1165.6 million by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032).

The global fibrin sealants market is experiencing robust growth, primarily driven by an increase in surgical procedures influenced by an aging population more prone to chronic diseases needing surgical care like cardiovascular issues and cancer. As surgeries become more frequent and complex, the demand for effective hemostatic agents rises, with fibrin sealants being favored for their ability to quickly form stable clots, reduce blood loss, and expedite recovery. Furthermore, advancements in biologic and recombinant DNA technologies are producing safer, more effective sealants with extended shelf lives and reduced immunogenic risks, enabling the production of synthetic and pathogen-free options. These innovations are enhancing adhesion, polymerization speed, and overall surgical outcomes, thereby broadening the clinical adoption of fibrin sealants in modern medicine.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fibrin Sealants market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Fibrin Sealants Market Segments Analysis

Global Fibrin Sealants Market is segmented by Product Type, Technology, Application, End User and region. Based on Product Type, the market is segmented into Liquid, Patches, Powder and Others. Based on Technology, the market is segmented into Viral Inactivation, Autologous Donation, Recombinant Production and Others. Based on Application, the market is segmented into Orthopedic Surgery, Cardiovascular surgery, General Surgery, Transplant Surgery and Others. Based on End User, the market is segmented into Hospitals, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Fibrin Sealants Market

The global fibrin sealants market is significantly influenced by the increasing volume of surgical procedures taking place across the globe. This rise is largely attributed to the higher prevalence of chronic conditions such as cardiovascular diseases, cancer, and orthopedic issues. Consequently, there is a heightened demand for effective hemostatic agents, particularly fibrin sealants, which facilitate improved surgical outcomes. As more patients undergo surgeries to address these health concerns, the need for reliable and efficient solutions like fibrin sealants continues to expand, further propelling the growth of the market over time.

Restraints in the Global Fibrin Sealants Market

The global fibrin sealants market faces significant restraints due to regulatory challenges and prolonged approval timelines for fibrin sealant products. These obstacles slow down market expansion as the necessity for comprehensive clinical trials and adherence to regulations in various regions extends development periods. Consequently, this limits the introduction of new and innovative fibrin sealant solutions, potentially hindering access to advanced treatment options for healthcare providers and patients alike. As the market grapples with these regulatory complexities, the overall growth and evolution of fibrin sealant offerings may be significantly affected, impacting industry dynamics in the long run.

Market Trends of the Global Fibrin Sealants Market

The Global Fibrin Sealants market is witnessing a significant surge, predominantly fueled by the rising preference for minimally invasive surgeries. As healthcare providers increasingly prioritize patient safety and quicker recovery times, fibrin sealants have emerged as a vital tool, enhancing surgical efficacy by reducing blood loss and promoting faster healing. This trend is particularly evident in critical fields such as cardiovascular and orthopedic surgery, where precision and rapid postoperative recovery are paramount. As a result, the demand for these biological adhesives is projected to escalate, positioning fibrin sealants as indispensable components in modern surgical practice, thereby shaping the future of surgical interventions worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Fibrin Sealants Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Liquid
  • Frozen fibrin sealants
  • Freeze dried fibrin sealants
• Patches
• Powder
• Others

Global Fibrin Sealants Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Viral Inactivation
• Autologous Donation
• Recombinant Production
• Others

Global Fibrin Sealants Market Size by Application & CAGR (2025-2032)

• Market Overview
• Orthopedic Surgery
• Cardiovascular surgery
• General Surgery
• Transplant Surgery
• Others

Global Fibrin Sealants Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Specialty Clinics
• Others

Global Fibrin Sealants Market Size & CAGR (2025-2032)

• North America (Product Type, Technology, Application, End User)
  • US
  • Canada
• Europe (Product Type, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Baxter International (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vivostat A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols, S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hemarus (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Z-Medica (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marquee Biosurgical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hualan Biological Engineering (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corza Medical (USA/Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cohera Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Medical Solutions Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ocular Therapeutix, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroVal (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations